Shannon Thyme Klinger - 07 Mar 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: Chief Legal Officer
Signature: /s/ James Dillon, as Attorny-in-Fact
Issuer symbol: MRNA
Transactions as of: 07 Mar 2025
Net transactions value: -$18,899
Form type: 4
Filing time: 10 Mar 2025, 16:08:45 UTC
Previous filing: 03 Mar 2025
Next filing: 29 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+1,139	+4.6%		26,163	07 Mar 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$18,899	-551	-2.1%	$34.30	25,612	07 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-1,139	-50%	$0.000000	1,139	07 Mar 2025	Common Stock	1,139		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	25% of the shares subject to this restricted stock unit award vested on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.